Invention Grant
- Patent Title: Cancer diagnostic tool using cancer genomic signatures to determine cancer type
-
Application No.: US15709407Application Date: 2017-09-19
-
Publication No.: US10685738B1Publication Date: 2020-06-16
- Inventor: Zurab Kakushadze
- Applicant: Quantigic Genomics LLC
- Applicant Address: US CT Stamford
- Assignee: Quantigic Genomics LLC
- Current Assignee: Quantigic Genomics LLC
- Current Assignee Address: US CT Stamford
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: G16B20/00
- IPC: G16B20/00 ; G01N33/574 ; G16B25/00 ; G16B30/00 ; G16B40/00

Abstract:
Cancer types (e.g., organ/tissue of origin and/or cancer subtype for an organ/tissue) can be distinguished by applying statistical methods to data samples consisting of counts of somatic single nucleotide variations (SNVs) across a tumor genome of a patient. For example, a factor loading matrix for each cancer type to be distinguished can be computed using a set of training data samples for which the cancer type is known. To determine the cancer type for a testing (or diagnostic) data sample, a regression analysis over the set of factor loading matrices yields statistical parameters that can be used to identify the cancer type.
Information query